Trial Profile
Efficacy of sugammadex in reversal of rocuronium-induced neuromuscular blockade in patients with Myasthenia Gravis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Aug 2014
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 07 Aug 2014 New trial record